Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells
Open Access
- 29 January 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (5) , 971-977
- https://doi.org/10.1038/sj.bjc.6690155
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative groupEuropean Journal Of Cancer, 1998
- Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study.Journal of Clinical Oncology, 1997
- Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.Journal of Clinical Oncology, 1997
- Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reactionJournal of Pediatric Surgery, 1997
- Diagnostic PCR in melanoma, methods and quality assurance. Epalinges, Switzerland, 26/27 January 1996European Journal Of Cancer, 1996
- Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNAEuropean Journal Of Cancer, 1995
- Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNAInternational Journal of Cancer, 1994
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991
- Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.Journal of Clinical Pathology, 1989
- Simple and Rapid Preparation of Samples for PCRPublished by Springer Nature ,1989